The tall, rapidly growing infant, child, and adolescent

Current Opinion in Endocrinology and Diabetes

Volumn 8, Issue 1, 2001, Pages 6-16

  Root, A W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR BLOCKING AGENT; HYDROCORTISONE; PEGVISOMANT; SEX HORMONE; SOMATOMEDIN B; SOMATOSTATIN; TESTOSTERONE ESTER; UNCLASSIFIED DRUG;

ADOLESCENT; BONE AGE; CHILD; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; GENETIC ANALYSIS; GROWTH REGULATION; HEREDITY; HUMAN; HYPOPHYSIS ADENOMA; INFANT; MULTIPLE ENDOCRINE NEOPLASIA; OBESITY; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; REVIEW; SYNDROME; TALL STATURE; THYROTOXICOSIS;

EID: 0035140096     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200102000-00003     Document Type: Review

References (47)

1. Sex steroid treatment of constitutionally tall stature
2. The genetic contribution to stature
3. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone
4. SHOX: Growth, Leri-Weill and Turners syndromes
5. Short stature homeobox-containing gene duplication on the der(X) chromosome in a female with 45,X/46,X,der(X), gonadal dysgenesis, and tall stature
6. Drosophila S6 kinase: A regulator of cell size
7. All creatures great and small
8. Normal growth and development in the absence of hepatic insulin-like growth factor-I
9. Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system
10. Ghrellin is a growth-hormone-releasing acylated peptide from stomach
11. Growth hormone and bone
12. Growth and estrogen
13. Estrogen receptor null mice: What have we learned and where will they lead us?
14. Overgrowth syndromes: An update
15. Analyses of 24-hour growth hormone profiles in children: Relation to growth
16. Correlation of the parameters of 24-hour growth hormone secretion with growth velocity in 93 children of varying height
17. Growth hormone response to thyrotropin releasing hormone and oral glucose-loading tests in tall children and adolescents
18. Growth hormone secretion in children and adolescents with familial tall stature
19. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents
20. Aggressive behavior in patients with Sotos syndrome
21. Growth in Sotos syndrome
22. The syndromes of Sotos and Weaver: Reports and review
23. Severe Lhermitte-Duclos disease with a unique germline mutation of PTEN
24. Commentary: Gigantism
25. Clinical and immunohistochemical findings in a case of neonatal Marfan syndrome
26. Molecular studies of the etiology of trisomy 8 in spontaneous abortions and the liveborn population
27. Newer aspects of the pathophysiology, evaluation, and management of obesity in childhood
28. Body mass index and child obesity: Are we nearing a definition?
29. Leptin: Molecular biology, physiology, and relevance to pediatric practice
30. Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin
31. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research Office Settings Network
32. Editorial. Precocious puberty: Who has it? Who should be treated?
33. Precocious puberty
34. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: Relation to reduced fetal growth
35. Pronounced adrenarche and precocious pubarche in boys
36. Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma
37. Commentary: Pediatric pituitary adenomas
38. Pituitary tumors in children and adolescents
39. Growth evaluation: Parent and child specific height standards
40. Advances in diagnosis of acromegaly
41. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues
42. Diagnosis and treatment of central precocious puberty: State of the art 1999
43. Current therapy for acromegaly
44. Stereotactic radiosurgery for pituitary adenomas
45. Rational drug design based on structure and mechanism of action
46. Treatment of acromegaly with Pegvisomant, a genetically engineered human growth-hormone receptor antagonist
47. Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs